NKCC1: A key regulator of glioblastoma progression.
Saved in:
| Title: | NKCC1: A key regulator of glioblastoma progression. |
|---|---|
| Authors: | Thomsen A; Department of Neurology, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany., Freitag D; Department of Neurosurgery, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany.; Experimental Trauma Surgery, Department of Trauma, Hand and Reconstructive Surgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany., Haase M; Department of Neurology, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany., Senft C; Department of Neurosurgery, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany., Schwarz F; Department of Neurosurgery, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany., Keiner S; Department of Neurology, Jena University Hospital-Friedrich-Schiller University Jena, Jena, Germany.; Jena Centre for Healthy Aging, Jena University Hospital, Jena, Germany. |
| Source: | Molecular oncology [Mol Oncol] 2026 Jun; Vol. 20 (6), pp. 1420-1428. Date of Electronic Publication: 2026 Mar 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
